Human Leukocyte Antigen Testing Market Global Report 2021, 28
The human leukocyte antigen (HLA) testing market is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is expected to register a CAGR of 7.5% from 2022 to 2028.
Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for HLA testing is to match organ and tissue transplant recipients with compatible donors. The HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.
The report offers insights and in-depth analysis of the human leukocyte antigen (HLA) testing market emphasizing market trends, technological advancements, and market dynamics, among others. It also provides the competitive landscape analysis of the globally leading market players. Furthermore, it includes the impact of the COVID-19 pandemic on the market across all the major regions. The COVID-19 pandemic created both a public health crisis and an economic crisis worldwide. Before the pandemic, the human leukocyte antigen (HLA) testing market was growing continuously owing to the regularity in the assessment of organ donors, consolations, and treatments. The first wave of COVID-19 disrupted the consultations, follow-ups, and screenings related to diseases other than COVID-19. Several companies experienced severe losses in the last quarter of 2019; the pandemic particularly had adverse effects on the global market in the first and second quarters of 2020. Businesses worldwide were hampered due to disruption in supply chains, and increased demand for healthcare products and services. To reduce COVID-19 infection in hospitals and clinics, healthcare practitioners and patients adopted and preferred treating their patients remotely. These unforeseeable circumstances also hampered organ transplantation procedures. Many surgical treatments and non-urgent consultations were canceled or postponed, and elective surgeries were suspended in many institutions to limit the spread of SARS-CoV-2 as well as to reserve and reallocate resources, including healthcare personnel (nurses and anesthesiologists), medical equipment (personal protective equipment and ventilators), and beds. The "stay at home" recommendation resulted in a significant reduction in organ donation and organ transplantation surgeries. These conditions restrained the growth of the human leukocyte antigen (HLA) testing market worldwide in 2020.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Human Leukocyte Antigen (HLA) Testing Market: Strategic Insights
Market Size Value in US$ 697.74 Million in 2021 Market Size Value by US$ 1,155.65 Million by 2028 Growth rate CAGR of 7.5% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Human Leukocyte Antigen (HLA) Testing Market: Strategic Insights
| Market Size Value in | US$ 697.74 Million in 2021 |
| Market Size Value by | US$ 1,155.65 Million by 2028 |
| Growth rate | CAGR of 7.5% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Increasing Number of Plasma Donation and Organ Transplantation Procedures Drive Market Growth
Increasing Number of Plasma Donation and Organ Transplantation Procedures Drive Market Growth
Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.
Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization.
Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.
Product and Services-Based Insights
Based on product and services, the human leukocyte antigen (HLA) testing market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market, and it is expected to register the fastest CAGR of 7.5% during the forecast period.
Technology-Based Insights
Based on technology, the human leukocyte antigen (HLA) testing market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a largest share of the market, and it is expected to record a higher CAGR of 7.7% during 2022–2028.
End User-Based Insights
Based on end user, the human leukocyte antigen (HLA) testing market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. However, hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022–2028
The human leukocyte antigen (HLA) testing market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide, along with meeting the growing product demands.
By Geography
Based on geography, the human leukocyte antigen (HLA) testing market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Human Leukocyte Antigen Testing Market Report Scope
Company Profiles
- Thermo Fisher Scientific Inc.
- CareDx
- Qiagen
- Illumina Inc.
- Bio-Rad Laboratories, Inc.
- TBG Diagnostics Limited
- F.Hoffmann-La Roche Ltd.
- Takara Bio Inc.
- Luminex Corporation
- Omixon Inc.
- The Sequencing Center
- Protrans
- HistoGenetics LLC.
- CD Genomics
- Qunitara Biosciences
- CeGat GmbH
- Creative Biolabs Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Services, Technology, and End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global human leukocyte antigen (HLA) testing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for human leukocyte antigen (HLA) testing market. The US is estimated to hold the largest share in the human leukocyte antigen (HLA) testing market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for human leukocyte antigen (HLA) testing accounting fastest growth of the region during the coming years.
Thermo Fisher Scientific, Inc., CareDx, Inc., Qiagen N.V., Illumina, Bio-Rad Laboratories, Inc., TGB Diagnostics Ltd., F. Hoffman La-Roche Ltd., Takara Bio, Luminex Corporation, Oximon, The Sequencing Center, Protrans, HistoGenetics LLC, CD Genomics, Quintara Biosciences, CeGaT GmbH, Creative Biolabs, Inc., are among the leading companies operating in the global human leukocyte antigen (HLA) testing market
The molecular assay technologies segment dominated the global human leukocyte antigen (HLA) testing market and is likely to account for the revenue of US$ 626.86 million in 2022.
Human leukocyte antigens play an essential part in the body's immune response to external substances. The principal use for human leukocyte antigen (HLA) testing is to match organ and tissue transplant recipients with compatible donors. HLA testing also involves screening transplant recipients for the presence of antibodies that might target the donated tissue or organ as part of an immune response.
Increasing plasma donation and organ transplants procedures is one of the most significant factors responsible for the overall market growth.
Based on product and service type, reagent and consumables took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market – By Product and Services
1.3.2 Global Human Leukocyte Antigen (HLA) Testing Market – By Technology
1.3.3 Global Human Leukocyte Antigen (HLA) Testing Market – By End User
1.3.4 Global Human Leukocyte Antigen (HLA) Testing Market – By Geography
2. Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Human Leukocyte Antigen (HLA) Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. Global Human Leukocyte Antigen (HLA) Testing Market – Global Analysis
6.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
6.1.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
6.1.2 Global Human Leukocyte Antigen (HLA) Testing Market – Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Thermo Fisher Scientific Inc
6.2.4.2 Illumina Corporation
7. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services
7.1 Overview
7.2 Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology
8.1 Overview
8.2 Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User
9.1 Overview
9.2 Global Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Geography
10.1 North America: Human Leukocyte Antigen (HLA) Testing Market
10.1.1 Overview
10.1.2 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.4 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.4.1 North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.5 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6 North America: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.1.3 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.1.3.1 US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.1.4 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.2 Canada: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.2 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.2.3 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.2.3.1 Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.2.4 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Mexico Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.3.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.3.3.1 Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.3.4 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2 Europe: Human Leukocyte Antigen (HLA) Testing Market
10.2.1 Overview
10.2.2 Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.4 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.4.1 Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.5 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6 Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Germany: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.1.3 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.1.3.1 Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.1.4 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.2 France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.2 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.2.3 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.2.3.1 France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.2.4 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.3 UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.3.3 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.3.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.3.4 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.4 Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.2 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.4.3 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.4.3.1 Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.4.4 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.5 Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.5.3 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.5.3.1 Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.5.4 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.6 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.6.3 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.6.3.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.6.4 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028
10.3.1 Overview
10.3.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.3.4 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.4.1 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.5 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
10.3.6.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.3.6.1.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.2 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.1.3 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.1.3.1 China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.1.4 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.2.3 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.2.3.1 Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.2.4 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.3 India Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.3.6.3.1 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.2 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.3.3 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.3.3.1 India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.3.4 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.3.6.4.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.2 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.4.3 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.4.3.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.4.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.5 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.2 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.5.3 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.5.3.1 Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.5.4 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.6 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.2 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.4.1 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.5 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.4.6.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.2 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.1.3 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.1.3.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.1.4 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.2 UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.2 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.2.3 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.2.3.1 UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.2.4 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.2 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.3.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.3.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.3.4 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.2 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.4.3.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.5 South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028
10.5.1 Overview
10.5.2 South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.5.4 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.5.4.1 South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.5 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America: Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
10.5.6.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.2 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)
10.5.6.1.3 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.6.1.4 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)
10.5.6.2.3 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.6.2.4 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.2 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)
10.5.6.3.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.6.3.4 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Geographic Regions
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment Of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment Of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 CareDx
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Illumina, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TBG Diagnostics Limited
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Takara Bio Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Luminex Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Omixon Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 The Sequencing Center
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Protrans
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 HistoGenetics LLC
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 CD Genomics
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Quintara Biosciences
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 CeGaT GmbH
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 CREATIVE BIOLABS, INC.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 2. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 3. North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 4. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 5. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 6. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 7. US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 8. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 9. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 10. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 11. Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 12. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 13. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 14. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 15. Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 16. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 17. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 18. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 19. Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 20. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 21. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 22. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 23. Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 24. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 25. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 26. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 27. France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 28. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 29. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 30. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 31. UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 32. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 33. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 34. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 35. Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 36. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 37. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 38. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 39. Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 40. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 41. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 42. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 43. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 44. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 45. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 46. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
Table 47. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 48. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 49. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 50. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 51. China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 52. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 53. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 54. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
Table 55. Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 56. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 57. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 58. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 59. India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 60. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 61. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 62. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 63. South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 64. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 65. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 66. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 67. Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 68. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 69. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 70. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 71. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 72. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 73. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 74. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 75. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 76. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 77. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 78. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 79. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 80. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 81. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 82. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 83. UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 84. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 85. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 86. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 87. South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 88. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 89. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
Table 90. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
Table 91. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 92. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
Table 93. South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 94. South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 96. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 98. Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 100. Brazil: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 102. Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 104. Argentina: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)
Table 106. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
Table 108. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 109. Organic Developments in the Human Leukocyte Antigen (HLA) Testing Market
Table 110. Inorganic Developments in the Human Leukocyte Antigen (HLA) Testing Market
Table 111. Glossary of Terms, Human Leukocyte Antigen (HLA) Testing Market
LIST OF FIGURES
Figure 1. Human Leukocyte Antigen (HLA) Testing Market Segmentation
Figure 2. Human Leukocyte Antigen (HLA) Testing Market Segmentation, By Region
Figure 3. Global Human Leukocyte Antigen (HLA) Testing Market Overview
Figure 4. Reagents And Consumables Held Largest Share of Product Segment in Human Leukocyte Antigen (HLA) Testing Market
Figure 5. Asia Pacific Region is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Human Leukocyte Antigen (HLA) Testing Market, By Geography (US$ Million)
Figure 7. Global Human Leukocyte Antigen (HLA) Testing Market- Leading Country Markets (US$ Million)
Figure 8. Global Human Leukocyte Antigen (HLA) Testing Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. HLA Testing Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 18. Global Human Leukocyte Antigen (HLA) Testing Market – Market Potential Analysis, By Region
Figure 19. Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market
Figure 20. Global Human Leukocyte Antigen (HLA) Testing Market – Comparative Company Analysis
Figure 21. Global Human Leukocyte Antigen (HLA) Testing Market – Growth Strategy Analysis
Figure 22. Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
Figure 23. Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 24. Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 25. Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 26. Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
Figure 27. Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Global Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)
Figure 33. Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)
Figure 37. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 38. North America: Human Leukocyte Antigen (HLA) Testing Market, By Country, 2022 & 2028 (%)
Figure 39. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 40. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 41. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 42. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
Figure 45. Germany: Human Leukocyte Antigen (HLA) Testing Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)
Figure 52. Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
Figure 54. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 55. Japan Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 56. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 57. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 58. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast To 2028 (US$ Million)
Figure 60. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 61. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
Figure 63. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 67. South and Central America Human Leukocyte Antigen (HLA) Testing Market Overview, by Country (2022)
Figure 68. South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. South and Central America Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
Figure 70. Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Impact of COVID-19 Pandemic on North American Country Markets
Figure 74. Impact of COVID-19 Pandemic on European Country Markets
Figure 75. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic on Middle East & Africa Country Markets
Figure 77. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 78. Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)
The List of Companies - Human Leukocyte Antigen (HLA) Market
- Thermo Fisher Scientific Inc.
- CareDx
- Qiagen
- Illumina Inc.
- Bio-Rad Laboratories, Inc.
- TBG Diagnostics Limited
- F.Hoffmann-La Roche Ltd.
- Takara Bio Inc.
- Luminex Corporation
- Omixon Inc.
- The Sequencing Center
- Protrans
- HistoGenetics LLC.
- CD Genomics
- Qunitara Biosciences
- CeGat GmbH
- Creative Biolabs Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For